检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:马慧颖[1] 刘翔宇 李文静[1] 崔竹梅[1] 王翔宇[1] Ma Huiying;Liu Xiangyu;Li Wenjing(Department of Gynecology,Qingdao University Affiliated Hospital,Qingdao266000)
出 处:《现代妇产科进展》2021年第8期571-574,共4页Progress in Obstetrics and Gynecology
摘 要:目的:探讨上皮性卵巢癌(EOC)患者血清中基质金属蛋白酶9(MMP-9)和白细胞介素8(IL-8)水平及临床意义。方法:选取120例EOC患者(恶性组)、27例卵巢良性疾病患者(良性组)、27例健康体检女性(对照组),比较血清MMP-9、IL-8水平,并分析两者水平与EOC临床病理学特征的关系及两者相关性。结果:恶性组血清MMP-9、IL-8水平均明显高于良性组和对照组,差异有统计学意义(P<0.01)。血清MMP-9、IL-8与卵巢癌患者FIGO分期、淋巴结转移、化疗效果有关(P<0.05),与年龄、分化程度、病理分型等无明显相关。MMP-9与IL-8表达水平具有正相关性(r_(s)=0.363,P<0.01)。结论:上皮性卵巢癌患者血清中MMP-9及IL-8均高表达,两者表达与FIGO分期、淋巴结转移、化疗敏感性有关,可作为卵巢癌诊疗中的重要参考指标。Objective:To investigate the levels and clinical significance of serum matrix metalloproteinase-9(MMP-9)and interleukin-8(IL-8)in patients with epithelial ovarian cancer(EOC).Methods:120 patients with EOC were enrolled in malignant group,27 patients with benign ovarian diseases in benign group and 27 healthy women in control group.The levels of serum MMP-9 and IL-8 were compared,and the correlation between them and the clinicopathological features of patients with EOC were analyzed.Results:The serum levels of MMP-9 and IL-8 in malignant group were significantly higher than those in benign group and control group(P<0.01).Serum MMP-9 and IL-8 were correlated with FIGO stage,lymph node metastasis and chemotherapy response in patients with EOC(P<0.05),but not with age,differentiation,pathological classification and so on.There was a positive correlation between serum MMP-9 and IL-8 expression(r s=0.363,P<0.01).Conclusion:MMP-9 and IL-8 are highly expressed in serum of patients with EOC,and their expression is related to FIGO stage,lymph node metastasis and chemosensitivity which can be used as an important reference index in the diagnosis and treatment of ovarian cancer.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.70